Coronavirus company news summary – Co-Diagnostics to offer at-home saliva collection kits for Covid-19 PCR test – NIH awards UC San Diego $33m for five Covid-19 diagnostic projects
Co-Diagnostics has announced that its laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorised saliva-based Covid-19 PCR test, which uses the company’s CoPrimer technology, is now available through Walgreens Find Care. The test gives consumers access to a convenient and non-invasive option for PCR-based Covid-19 testing from their homes.
The University of California San Diego has been awarded $33m by the National Institutes of Health (NIH) for five rapid acceleration of diagnostics (RADx) projects. The purpose of the RADx effort is to accelerate innovation in the development, implementation, and commercialisation of the technologies needed for Covid-19 testing.
The ongoing International Defence Exhibition (Idex) in Abu Dhabi has displayed the world’s first artificial intelligence (AI)-driven rapid Covid-19 antigen test system that delivers real-time coronavirus test results in just five minutes. The LooK SPOT AI Covid-19 antigen rapid test has been developed by Laipac Technology, alongside YAS Pharmaceuticals and Pure Health.
CityHealth has announced the launch of a new in-home Covid-19 test kit that allows infected patients to conduct medically supervised Covid-19 tests on their own in their homes. The test kit costs $39 for US residents, one of the most affordable remote testing kit available in the market.